 | • レポートコード：GIR-105X07786 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子ワクチンの種類別市場規模（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別市場規模（人、動物）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：組換えタンパク質ワクチン、遺伝子ベースワクチン ・用途別分析2016年-2026年：人、動物 ・遺伝子ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genetic Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genetic Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Genetic Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Genetic Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Recombinant Protein Vaccine
Gene-Based Vaccine
Market segment by Application can be divided into
Human
Animal
The key market players for global Genetic Vaccine market are listed below:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Genetic Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genetic Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Genetic Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Human
1.3.3 Animal
1.4 Global Genetic Vaccine Market Size & Forecast
1.4.1 Global Genetic Vaccine Sales in Value (2016-2026))
1.4.2 Global Genetic Vaccine Sales in Volume (2016-2026)
1.4.3 Global Genetic Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Genetic Vaccine Production Capacity Analysis
1.5.1 Global Genetic Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Genetic Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Vaccine Market Drivers
1.6.2 Genetic Vaccine Market Restraints
1.6.3 Genetic Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Genetic Vaccine Product and Services
2.1.4 Merck Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Genetic Vaccine Product and Services
2.2.4 GSK Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Genetic Vaccine Product and Services
2.3.4 Sanofi Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Zoties
2.4.1 Zoties Details
2.4.2 Zoties Major Business
2.4.3 Zoties Genetic Vaccine Product and Services
2.4.4 Zoties Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Genetic Vaccine Product and Services
2.5.4 Elanco Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Boehringer-Ingelheim
2.6.1 Boehringer-Ingelheim Details
2.6.2 Boehringer-Ingelheim Major Business
2.6.3 Boehringer-Ingelheim Genetic Vaccine Product and Services
2.6.4 Boehringer-Ingelheim Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals Genetic Vaccine Product and Services
2.7.4 Indian Immunologicals Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Plumbline Life Sciences
2.8.1 Plumbline Life Sciences Details
2.8.2 Plumbline Life Sciences Major Business
2.8.3 Plumbline Life Sciences Genetic Vaccine Product and Services
2.8.4 Plumbline Life Sciences Genetic Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Genetic Vaccine Sales by Manufacturer
3.1 Global Genetic Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Genetic Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Genetic Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Genetic Vaccine Manufacturer Market Share
3.4.2 Top 6 Genetic Vaccine Manufacturer Market Share
3.5 Global Genetic Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Genetic Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Genetic Vaccine Market Size by Region
4.1.1 Global Genetic Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Genetic Vaccine Revenue by Region (2016-2026)
4.2 North America Genetic Vaccine Revenue (2016-2026)
4.3 Europe Genetic Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Genetic Vaccine Revenue (2016-2026)
4.5 South America Genetic Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Genetic Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Genetic Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Genetic Vaccine Revenue by Type (2016-2026)
5.3 Global Genetic Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Genetic Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Genetic Vaccine Revenue by Application (2016-2026)
6.3 Global Genetic Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Genetic Vaccine Sales by Type (2016-2026)
7.2 North America Genetic Vaccine Sales by Application (2016-2026)
7.3 North America Genetic Vaccine Market Size by Country
7.3.1 North America Genetic Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Genetic Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Genetic Vaccine Sales by Type (2016-2026)
8.2 Europe Genetic Vaccine Sales by Application (2016-2026)
8.3 Europe Genetic Vaccine Market Size by Country
8.3.1 Europe Genetic Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Genetic Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Genetic Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Genetic Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Genetic Vaccine Market Size by Region
9.3.1 Asia-Pacific Genetic Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Genetic Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Genetic Vaccine Sales by Type (2016-2026)
10.2 South America Genetic Vaccine Sales by Application (2016-2026)
10.3 South America Genetic Vaccine Market Size by Country
10.3.1 South America Genetic Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Genetic Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Genetic Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Genetic Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Genetic Vaccine Market Size by Country
11.3.1 Middle East & Africa Genetic Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Genetic Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Genetic Vaccine Typical Distributors
12.3 Genetic Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Genetic Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Genetic Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Genetic Vaccine Product and Services
Table 6. Merck Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Genetic Vaccine Product and Services
Table 10. GSK Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Genetic Vaccine Product and Services
Table 14. Sanofi Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Zoties Basic Information, Manufacturing Base and Competitors
Table 16. Zoties Major Business
Table 17. Zoties Genetic Vaccine Product and Services
Table 18. Zoties Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Major Business
Table 21. Elanco Genetic Vaccine Product and Services
Table 22. Elanco Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer-Ingelheim Major Business
Table 25. Boehringer-Ingelheim Genetic Vaccine Product and Services
Table 26. Boehringer-Ingelheim Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 28. Indian Immunologicals Major Business
Table 29. Indian Immunologicals Genetic Vaccine Product and Services
Table 30. Indian Immunologicals Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Plumbline Life Sciences Major Business
Table 33. Plumbline Life Sciences Genetic Vaccine Product and Services
Table 34. Plumbline Life Sciences Genetic Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Genetic Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Genetic Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Genetic Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Genetic Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Genetic Vaccine Production Site of Key Manufacturer
Table 40. Global Genetic Vaccine Sales by Region (2016-2021e) & (K Units)
Table 41. Global Genetic Vaccine Sales by Region (2021-2026) & (K Units)
Table 42. Global Genetic Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Genetic Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 45. Global Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Global Genetic Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Genetic Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Genetic Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Genetic Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 51. Global Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Global Genetic Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Genetic Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Genetic Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Genetic Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Genetic Vaccine Sales by Country (2016-2021e) & (K Units)
Table 57. North America Genetic Vaccine Sales by Country (2021-2026) & (K Units)
Table 58. North America Genetic Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Genetic Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 61. North America Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 62. North America Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 63. North America Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 64. Europe Genetic Vaccine Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Genetic Vaccine Sales by Country (2021-2026) & (K Units)
Table 66. Europe Genetic Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Genetic Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 70. Europe Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Genetic Vaccine Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Genetic Vaccine Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Genetic Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Genetic Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 80. South America Genetic Vaccine Sales by Country (2016-2021e) & (K Units)
Table 81. South America Genetic Vaccine Sales by Country (2021-2026) & (K Units)
Table 82. South America Genetic Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Genetic Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 85. South America Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 86. South America Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 87. South America Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Genetic Vaccine Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Genetic Vaccine Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Genetic Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Genetic Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Genetic Vaccine Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Genetic Vaccine Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Genetic Vaccine Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Genetic Vaccine Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Genetic Vaccine Typical Distributors
Table 99. Genetic Vaccine Typical Customers
List of Figures
Figure 1. Genetic Vaccine Picture
Figure 2. Global Genetic Vaccine Sales Market Share by Type in 2020
Figure 3. Recombinant Protein Vaccine
Figure 4. Gene-Based Vaccine
Figure 5. Global Genetic Vaccine Sales Market Share by Application in 2020
Figure 6. Human
Figure 7. Animal
Figure 8. Global Genetic Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Genetic Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Genetic Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Genetic Vaccine Sales (2016-2026) & (K Units)
Figure 30. Global Genetic Vaccine Production Capacity (2016-2026) & (K Units)
Figure 31. Global Genetic Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Genetic Vaccine Market Drivers
Figure 33. Genetic Vaccine Market Restraints
Figure 34. Genetic Vaccine Market Trends
Figure 35. Global Genetic Vaccine Sales Market Share by Manufacturer in 2020
Figure 36. Global Genetic Vaccine Revenue Market Share by Manufacturer in 2020
Figure 37. Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Genetic Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Genetic Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Genetic Vaccine Sales Market Share by Region (2016-2026)
Figure 41. Global Genetic Vaccine Revenue Market Share by Region (2016-2026)
Figure 42. North America Genetic Vaccine Revenue (2016-2026) & (USD Million)
Figure 43. Europe Genetic Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Genetic Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. South America Genetic Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Genetic Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Global Genetic Vaccine Sales Market Share by Type (2016-2026)
Figure 48. Global Genetic Vaccine Revenue Market Share by Type (2016-2026)
Figure 49. Global Genetic Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 51. Global Genetic Vaccine Revenue Market Share by Application (2016-2026)
Figure 52. Global Genetic Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Genetic Vaccine Sales Market Share by Country (2016-2026)
Figure 54. North America Genetic Vaccine Revenue Market Share by Country (2016-2026)
Figure 55. North America Genetic Vaccine Sales Market Share by Type (2016-2026)
Figure 56. North America Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 57. Europe Genetic Vaccine Sales Market Share by Country (2016-2026)
Figure 58. Europe Genetic Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. Europe Genetic Vaccine Sales Market Share by Type (2016-2026)
Figure 60. Europe Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Genetic Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Genetic Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Genetic Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Genetic Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Genetic Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. South America Genetic Vaccine Sales Market Share by Type (2016-2026)
Figure 68. South America Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Genetic Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Genetic Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Genetic Vaccine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Genetic Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- 世界のガーダシル（HPVワクチン）市場 2021：企業別、地域別、種類・用途別 The Gardasil (HPV Vaccine) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- ヒトのワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administ…
- 世界の4価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Quadrivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の子宮頸がんワクチン市場 2021：企業別、地域別、種類・用途別 The Cervical Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…